Works matching DE "ADALIMUMAB"

Results: 2275

Association Between Biologics and Janus Kinase Inhibitors With Inflammatory Bowel Disease as Paradoxical Reactions: A Real‐World Assessment.

Published in:

United European Gastroenterology Journal, 2025, v. 13, n. 4, p. 531, doi. 10.1002/ueg2.12719

By:

Zhan, Zhi‐Qing;
Li, Jia‐Xin;
Chen, Ying‐Xuan;
Fang, Jing‐Yuan

Publication type:

Article

Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis.

Published in:

United European Gastroenterology Journal, 2025, v. 13, n. 4, p. 552, doi. 10.1002/ueg2.12705

By:

Armuzzi, Alessandro;
Vermeire, Séverine;
Chaparro, María;
Biedermann, Patricia;
Brown, Rebecca;
McStravick, Megan;
Meyer, Marlies;
Schreiber, Stefan

Publication type:

Article

'I don't worry about going outside anymore': a patient's journey with recalcitrant lupus pernio responsive to adalimumab.

Published in:

Clinical & Experimental Dermatology, 2025, v. 50, n. 6, p. 1256, doi. 10.1093/ced/llaf027

By:

Duff, Eimear;
Feighery, Cliona

Publication type:

Article

General dermatology and dermatology in primary healthcare.

Published in:

Clinical & Experimental Dermatology, 2025, v. 50, n. 6, p. 1262, doi. 10.1093/ced/llaf025

By:

Aydemir, Ahmet Taha;
Boyvat, Ayse;
Akay, Bengu Nisa

Publication type:

Article

Tuberculosis screening in patients with hidradenitis suppurativa on tumour necrosis factor inhibitors: a retrospective chart review.

Published in:

Clinical & Experimental Dermatology, 2025, v. 50, n. 6, p. 1193, doi. 10.1093/ced/llaf014

By:

Byrnes, Katherine G;
Flowers, Richard H

Publication type:

Article

Identifying Risk Factors for Poor Efficacy of Adalimumab Treatment in Patients With Crohn's Disease: Insights From Machine Learning Models.

Published in:

Dermatologic Therapy, 2025, v. 2025, p. 1, doi. 10.1155/dth/1996661

By:

Li, Xiaojun;
Tang, Maomao;
Zhang, Jie;
Wang, Yongjun;
Wang, Chunlian;
Ouyang, Chunhui;
Cho, Yung-Tsu

Publication type:

Article

Evaluation of Methods Employed in Establishing Preclinical Similarity of Adalimumab Biosimilars.

Published in:

Advances in Pharmacological & Pharmaceutical Sciences, 2025, v. 2025, p. 1, doi. 10.1155/adpp/8816591

By:

Nair, Ramya;
Krishnan, Naveen;
Shenoy, Vasudev;
Seetharam, Raviraja N.;
Mudigonda, Koteshwara

Publication type:

Article

A case of pulmonary and cutaneous sarcoidosis.

Published in:

Breathe, 2025, v. 21, n. 2, p. 1, doi. 10.1183/20734735.0228-2024

By:

Foley, Eimear;
Basirat, Ahmad;
Yadav, Ankit;
O'Brien, Shane;
Mitchell, Patrick D.;
Donnelly, Seamas C.

Publication type:

Article

Development of Extramusculoskeletal Manifestations in Upadacitinib‐Treated Patients With Psoriatic Arthritis or Axial Spondyloarthritis.

Published in:

Arthritis & Rheumatology, 2025, v. 77, n. 5, p. 536, doi. 10.1002/art.43069

By:

Poddubnyy, Denis;
Parikh, Bhumik;
Elewaut, Dirk;
Navarro‐Compán, Victoria;
Siebert, Stefan;
Paley, Michael;
Coombs, Derek;
Lagunes, Ivan;
Biljan, Ana;
Nakasato, Priscila;
Wung, Peter;
Lubrano, Ennio

Publication type:

Article

Safety and efficacy of adalimumab 40 mg every 3 weeks in pediatric‐onset Crohn's disease.

Published in:

Journal of Pediatric Gastroenterology & Nutrition, 2025, v. 80, n. 6, p. 998, doi. 10.1002/jpn3.70036

By:

Elimeleh, Yotam;
Feler, Anat Y.;
Badarni, Rula T.;
Lahad, Avishay;
Rinawi, Firas

Publication type:

Article

Adalimumab-induced CNS demyelination in a patient with multiple pre-existing autoimmune diseases: Treatment contemplation.

Published in:

Modern Rheumatology Case Reports, 2025, v. 9, n. 1, p. 75, doi. 10.1093/mrcr/rxae069

By:

Khosravi, Sepehr;
Zamani, Babak;
Motamed, Mohammad Reza;
Akhoundi, Fahimeh H.

Publication type:

Article

The Persistent Wound: Plasmablastic Lymphoma in a Perianal Fistula.

Published in:

ACG Case Reports Journal, 2025, v. 12, n. 5, p. 1, doi. 10.14309/crj.0000000000001705

By:

Lutfallah, Salim C.;
Bobo, John F. G.;
Jetly-Shridhar, Rachna;
Loganantharaj, Nisha

Publication type:

Article

Antitumor Necrosis Factor-Refractory Esophageal Lesions in Crohn’s Disease Successfully Treated With Upadacitinib.

Published in:

ACG Case Reports Journal, 2025, v. 12, n. 5, p. 1, doi. 10.14309/crj.0000000000001713

By:

Naohiro Nakamura;
Yusuke Honzawa;
Yuka Ito;
Yasuki Sano;
Naoto Yagi;
Eiko Saito;
Norimasa Fukata;
Makoto Naganuma

Publication type:

Article

An 11‐Year‐Old Male With Periorbital Edema and Painful Subcutaneous Nodules.

Published in:

Pediatric Dermatology, 2025, v. 42, n. 3, p. 649, doi. 10.1111/pde.15770

By:

Wang, Yixin Ally;
Khurana, Michele;
Yan, Albert C.

Publication type:

Article

Costs of dose escalation among ulcerative colitis patients treated with adalimumab in Germany.

Published in:

2019

By:

Pöllinger, Bernadette;
Schmidt, Wolfgang;
Imhoff, Heidi;
Seiffert, Anna;
Emmert, Martin

Publication type:

journal article

Cost-effectiveness of treatment with etanercept for psoriasis in Sweden.

Published in:

European Journal of Health Economics, 2012, v. 13, n. 2, p. 145, doi. 10.1007/s10198-010-0293-8

By:

Knight, Christopher;
Mauskopf, Josephine;
Ekelund, Mats;
Singh, Amitabh;
Yang, Shiyi;
Boggs, Robert

Publication type:

Article

High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 7, p. 1089, doi. 10.1007/s00228-024-03676-8

By:

San, Esma H.;
Egberts, Angelique;
van Dijck - van Boetzelaer, Caroline W. Th.;
West, Rachel L.;
Vasbinder, Erwin C.

Publication type:

Article

Efficacy and safety of adalimumab in pediatric patients with Crohn's disease: A systematic review and meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 3, p. 395, doi. 10.1007/s00228-023-03613-1

By:

Chen, Bin;
Zou, Zhuan;
Zhang, Xiaoyan;
Xiao, Dongqiong;
Li, Xihong

Publication type:

Article

Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 5, p. 891, doi. 10.1007/s00228-022-03294-2

By:

Cheli, Stefania;
Cozzi, Valeria;
Cattaneo, Dario;
Norsa, Lorenzo;
De Giacomo, Costantino;
Clementi, Emilio;
Moretti, Chiara

Publication type:

Article

Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 11, p. 1319, doi. 10.1007/s00228-016-2103-4

By:

Stawowczyk, Ewa;
Kawalec, Paweł;
Pilc, Andrzej

Publication type:

Article

A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS).

Published in:

2016

By:

Ternant, David;
Paintaud, Gilles;
Trachtman, Howard;
Gipson, Debbie;
Joy, Melanie

Publication type:

Letter

Pharmacokinetics of adalimumab in Crohn's disease.

Published in:

2015

By:

Ternant, David;
Karmiris, Konstantinos;
Vermeire, Severine;
Desvignes, Céline;
Azzopardi, Nicolas;
Bejan-Angoulvant, Theodora;
Assche, Gert;
Paintaud, Gilles

Publication type:

Letter

Efficacy and safety of adalimumab for the Crohn's disease: a systematic review and meta-analysis of published randomized placebo-controlled trials.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 8, p. 907, doi. 10.1007/s00228-014-1702-1

By:

Song, Yun-Na;
Zheng, Ping;
Xiao, Jun-Hua;
Lu, Zhan-Jun

Publication type:

Article

Structure-based development and optimization of therapy antibody drugs against TNFα.

Published in:

Amino Acids, 2015, v. 47, n. 6, p. 1259, doi. 10.1007/s00726-015-1954-9

By:

Fu, Wenyan;
Wang, Xiaoze;
Yang, Weili;
Takeda, Hiroaki;
Hu, Shi;
Lou, Zhiyong;
Zhao, Jian;
Bethune, Augus;
Guo, Yajun

Publication type:

Article

Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy.

Published in:

Digestive Diseases, 2024, v. 42, n. 4, p. 325, doi. 10.1159/000535647

By:

Sokic-Milutinovic, Aleksandra;
Milosavljevic, Tomica

Publication type:

Article

Comparative Analysis of the 3-Year Persistence Rate with Second-Line Vedolizumab and Tumor Necrosis Factor-α Inhibitors in Patients with Inflammatory Bowel Disease Followed in Gastroenterology Practices in Germany.

Published in:

Digestive Diseases, 2020, v. 38, n. 6, p. 466, doi. 10.1159/000506121

By:

Helwig, Ulf;
Braegger, Fiona;
Kostev, Karel;
Schmidt, Carsten

Publication type:

Article

Pregnancy Outcomes of Patients Exposed to Adalimumab in Japan.

Published in:

Digestive Diseases, 2019, v. 37, n. 2, p. 123, doi. 10.1159/000493462

By:

Kawai, Yumi;
Tsuchiya, Tsuyoshi;
Aoki, Shigeru

Publication type:

Article

Front & Back Matter.

Published in:: Digestive Diseases, 2018, v. 37, n. 1, p. N.PAG
Publication type:: Article

Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice.

Published in:

Digestive Diseases, 2018, v. 37, n. 1, p. 11, doi. 10.1159/000493121

By:

Sugimoto, Ken;
Ikeya, Kentaro;
Kato, Masaichi;
Matsuura, Ai;
Watanabe, Fumitoshi;
Takano, Ryosuke;
Tamura, Satoshi;
Tani, Shinya;
Osawa, Satoshi;
Hanai, Hiroyuki

Publication type:

Article

Comparison of Survival and Retention Rates between Infliximab and Adalimumab for Psoriasis: 10-Year Experience at a Single Tertiary Center.

Published in:

Dermatology (10188665), 2023, v. 239, n. 3, p. 355, doi. 10.1159/000529964

By:

Onsun, Nahide;
Güneş, Begüm;
Kaya, Gökhan;
Güçkan Işık, Bengisu;
Yabacı Tak, Ayşegül

Publication type:

Article

Staphylococcus aureus Carriage in Hidradenitis Suppurativa: Impact on Response to Adalimumab.

Published in:

Dermatology (10188665), 2021, v. 237, n. 3, p. 372, doi. 10.1159/000512617

By:

Stergianou, Dimitra;
Tzanetakou, Vassiliki;
Argyropoulou, Maria;
Kanni, Theodora;
Bagos, Pantelis G.;
Giamarellos-Bourboulis, Evangelos J.

Publication type:

Article

Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa.

Published in:

2020

By:

Zouboulis, Christos C.;
Hansen, Hendrik;
Caposiena Caro, Raffaele Dante;
Damiani, Giovanni;
Delorme, Isabelle;
Pascual, José Carlos;
Reguiai, Ziad;
Trigoni, Anastasia;
Vilarrasa, Eva;
Alfageme Roldán, Fernando;
Zouboulis, Christos C;
Caposiena Caro, Raffaele Dante;
Pascual, José Carlos;
Alfageme Roldán, Fernando

Publication type:

journal article

Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease Severity.

Published in:

2018

By:

Sun, Ziwen;
Shi, Xiaomin;
Wang, Yun;
Zhao, Yi

Publication type:

journal article

In Crohn Disease, Biologic Dose Escalation is Common During Maintenance Phase, Study Reveals.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

New insights on the interaction mechanism of rhTNFα with its antagonists Adalimumab and Etanercept.

Published in:

Biochemical Journal, 2020, v. 477, n. 17, p. 3299, doi. 10.1042/BCJ20200568

By:

Angélica Contreras, María;
Macaya, Luis;
Neira, Pedro;
Camacho, Frank;
González, Alaín;
Acosta, Jannel;
Montesino, Raquel;
Toledo, Jorge Roberto;
Sánchez, Oliberto

Publication type:

Article

Cost-Effectiveness of Biosimilars vs Leflunomide in Patients With Rheumatoid Arthritis.

Published in:

JAMA Network Open, 2024, v. 7, n. 6, p. e2418800, doi. 10.1001/jamanetworkopen.2024.18800

By:

Peng, Kuan;
Chan, Shirley C. W.;
Wang, Yang;
Cheng, Franco W. T.;
Yeung, Winnie W. Y.;
Jiao, Yuanshi;
Chan, Esther W. Y.;
Wong, Ian C. K.;
Lau, Chak-Sing;
Li, Xue

Publication type:

Article

Tumour necrosis factor inhibitor exposure and radiographic outcomes in Veterans with rheumatoid arthritis: a longitudinal cohort study.

Published in:

Rheumatology Advances in Practice, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1093/rap/rkz015

By:

Cannon, Grant W;
Erickson, Alan R;
Teng, Chia-Chen;
Huynh, Tina;
Austin, Sharon;
Wade, Sally W;
Stolshek, Bradley S;
Collier, David H;
Mutebi, Alex;
Sauer, Brian C

Publication type:

Article

Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian study.

Published in:

Global & Regional Health Technology Assessment, 2024, v. 11, n. 1, p. 191, doi. 10.33393/grhta.2024.3204

By:

Santoleri, Fiorenzo;
Abrate, Paolo;
Pestrin, Laura;
Pasut, Enrico;
Modesti, Germana;
Musicco, Felice;
Fulgenzio, Chiara;
Zuzolo, Eva;
Pieri, Gabriella;
Roperti, Martina;
Gazzola, Pietro;
Gambera, Marco;
Martignoni, Isabella;
Montresor, Valentina;
Guarino, Francesca;
Grossi, Laura;
Di Fabio, Letizia;
Roberti, Cristina;
Spoltore, Concetta;
Tinari, Gabriella

Publication type:

Article

Cost per responder for ixekizumab and other biologic drugs approved for the treatment of moderate-to-severe plaque psoriasis in Italy.

Published in:

Global & Regional Health Technology Assessment, 2019, v. 2019, p. 1, doi. 10.1177/2284240318822289

By:

Ravasio, Roberto;
Antonelli, Silvia;
Maiorino, Alessia;
Costanzo, Antonio;
Losi, Serena

Publication type:

Article

Long-Term Dose Optimization of Adalimumab via Dose Spacing in Patients with Psoriasis.

Published in:

Bioengineering (Basel), 2022, v. 9, n. 8, p. N.PAG, doi. 10.3390/bioengineering9080387

By:

Benzaquen, Michael;
Munshi, Mohammad;
Bossart, Simon;
Feldmeyer, Laurence;
Emelianov, Vladimir;
Yawalkar, Nikhil;
Cazzaniga, Simone;
Heidemeyer, Kristine

Publication type:

Article

Current and Emerging Targeted Therapies for Ulcerative Colitis.

Published in:

Visceral Medicine, 2023, v. 39, n. 2, p. 46, doi. 10.1159/000530983

By:

Pietschner, Robert;
Rath, Timo;
Neurath, Markus F.;
Atreya, Raja

Publication type:

Article

Subject Index Vol. 7, No. 1, 2022.

Published in:: Inflammatory Intestinal Diseases, 2022, v. 7, n. 1, p. 70, doi. 10.1159/000521668
Publication type:: Article

Stopping Anti-TNF in CD Remitters: Cons.

Published in:

Inflammatory Intestinal Diseases, 2022, v. 7, n. 1, p. 59, doi. 10.1159/000517961

By:

Kobayashi, Taku

Publication type:

Article

Early Lyme Borreliosis in Patients Treated with Tumour Necrosis Factor-Alfa Inhibitors.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 11, p. 1857, doi. 10.3390/jcm8111857

By:

Maraspin, Vera;
Bogovič, Petra;
Rojko, Tereza;
Ogrinc, Katarina;
Ružić-Sabljić, Eva;
Strle, Franc

Publication type:

Article

Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1646, doi. 10.3390/jcm8101646

By:

Ribaldone, Davide Giuseppe;
Caviglia, Gian Paolo;
Abdulle, Amina;
Pellicano, Rinaldo;
Ditto, Maria Chiara;
Morino, Mario;
Fusaro, Enrico;
Saracco, Giorgio Maria;
Bugianesi, Elisabetta;
Astegiano, Marco

Publication type:

Article

Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: Exploratory Analyses from RA-BEAM.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 9, p. 1394, doi. 10.3390/jcm8091394

By:

Fautrel, Bruno;
Kirkham, Bruce;
Pope, Janet E.;
Takeuchi, Tsutomu;
Gaich, Carol;
Quebe, Amanda;
Zhu, Baojin;
de la Torre, Inmaculada;
De Leonardis, Francesco;
Taylor, Peter C.

Publication type:

Article

Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 6, p. 831, doi. 10.3390/jcm8060831

By:

Taylor, Peter C.;
Lee, Yvonne C.;
Fleischmann, Roy;
Takeuchi, Tsutomu;
Perkins, Elizabeth L.;
Fautrel, Bruno;
Zhu, Baojin;
Quebe, Amanda K.;
Gaich, Carol L.;
Zhang, Xiang;
Dickson, Christina L.;
Schlichting, Douglas E.;
Patel, Himanshu;
Durand, Frederick;
Emery, Paul

Publication type:

Article

Palliative treatment of anal fistulas in Crohn's disease.

Published in:

ANZ Journal of Surgery, 2016, v. 86, n. 3, p. 148, doi. 10.1111/ans.13474

By:

Hermann, Jacek;
Eder, Piotr;
Banasiewicz, Tomasz;
Kołodziejczak, Barbara;
Łykowska‐Szuber, Liliana

Publication type:

Article

Epithelioid myxofibrosarcoma developing at the injection site of Adalimumab therapy for psoriatic synovitis.

Published in:

European Journal of Rheumatology, 2018, v. 5, n. 2, p. 131, doi. 10.5152/eurjrheum.2017.17083

By:

Farshid, Gelareh;
Prowse, Phoebe;
True, Barbara

Publication type:

Article

Re: Examination of the Significant Placebo Effect in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.

Published in:

Journal of Urological Surgery, 2015, v. 2, n. 4, p. 205, doi. 10.4274/jus.2015.04.007

By:

P. C., Bosch

Publication type:

Article